Delivery Order SPE2DB24D1021-SPE2DB24FESFE

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.96 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order, valued at $1,240.93, is for the procurement of 4566133505...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 500S medication. The contract has a ceiling value of $1,327.32 and is structured as a Firm Fixed Price Delivery Order, with a period of performance through May 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
This federal contract award, valued at $1,724.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.87 Firm Fixed Price Delivery Order contract is for the supply of BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product. The contract has a period of performance through February 12, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of various pharmaceutical products and medical supplies to support the U.S. government's medical requirements. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,345.86 and a completion date of August 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,196.07, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of various pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $3,871.95, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up...
This federal contract award, valued at $1,143.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FESFE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,389.38, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support government healthcare programs.

The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, from Amerisourcebergen to support military treatment facilities and other federal healthcare providers nationwide.

The contract does not have a set-aside designation and is scheduled for completion in June 2024. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain network to deliver critical care materials and a diverse range of medications to various defense and civilian agencies.

Generated 11/1/24, 10:18 AM